Articles from Biotech Financial Reports (August 1, 2003)

Title	Author	Type	Words
AKZO NOBEL REJECTS CRITICISM OF 2002 FINANCIAL STATEMENTS.		Brief Article	146
BIOGEN EXPECTS QUARTERLY EARNINGS TO BE UNEVEN DURING 2003.		Brief Article	278
COVALENT GROUP GETS $3.4 MILLION IN NEW BUSINESS AWARDS.			423
GENEREX REPORTS A NET LOSS OF $2.6 MILLION FOR THIRD QTR.		Brief Article	274
NORAC SIGNS LETTER OF INTENT FOR AMALGAMATION WITH VIREXX.		Brief Article	1963